|
| ANNOUNCEMENT The 79th Annual Meeting of Yokohama, Japan March 8 - 10, 2006 |
| We are delighted to inform you that The Seventy-ninth Annual Meeting of
The Japanese Pharmacological Society will be held in Yokohama, from March
8 to March 10, 2006. As the host of this meeting, we extend our warm invitation
to you to attend this conference at the PACIFICO YOKOHAMA. For further information, the members of the Society should refer to Folia
Pharmacologica Japonica and non-members should contact the secretariat
by E-mail. We encourage you to join this exciting meeting. Sincerely, Masayoshi Mishina Chairman of the 79th Annual Meeting |
| Contact Address: Secretariat Department of Molecular Neurobiology and Pharmacology Graduate School of Medicine, University of Tokyo Tokyo 113-0033, Japan E-mail: jps2006@m.u-tokyo.ac.jp Phone: +81-3-5841-3415 Fax: +81-3-5841-3570 URL: http://jps79.umin.jp/ |
| Scientific Program | ||
| ● | The scientific program for the Meeting consists of five Plenary Lectures, three Invited Lectures, three Educational Lectures, two Keynote Lectures, thirty Symposia, about three hundred oral presentations, and about six hundred poster presentations, covering all pharmacological fields. Prize Lectures by young investigators awarded by The Japanese Pharmacological Society are also planned. Topics for the lectures and symposia are as follows: | |
| Plenary Lectures (alphabetical order) | ||
| ● | “Molecular basis of muscular dystrophy and therapeutic strategies” | |
| Dr. Kevin P. Campbell | ||
| University of Iowa College of Medicine, U.S.A. | ||
| ● | “Distinct signal transduction pathways of physiologic and pathologic cardiac
hypertrophy” |
|
| Dr. Seigo Izumo | ||
| Novartis Institutes for Biomedical Research, U.S.A. | ||
| ● | “Prostanoid receptors; from cDNA cloning to translational research” |
|
| Dr. Shuh Narumiya | ||
| Kyoto University | ||
| ● | “Glutamate receptors - dynamic structure and subunit-specific signaling” | |
| Dr. Morgan Sheng | ||
| The Picower Center for Learning and Memory, Massachusetts Institute of Technology, USA | ||
| ● | “From genes to drugs for memory” |
|
| Dr. Tim Tully | ||
| Cold Spring Harbor Laboratory, U.S.A. | ||
| Invited Lectures | ||
| ● | “Metabolic Syndrome – Pathogenesis and Treatment Strategy” | |
| Dr. Takashi Kadowaki | ||
| University of Tokyo | ||
| ● | “Self-renewal of neural stem cells and CNS-repair” | |
| Dr. Hideyuki Okano Keio University |
||
| ● | “Pharmacogenomics of opioid drugs” | |
| Dr. Andrew Somogyi | ||
| The President of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT), Department of Clinical and Experimental Pharmacology, University of Adelaide, Australia | ||
| Educational Lectures | ||
| ● | “Do drugs suppress lethal arrhythmias?” | |
| Dr. Keitaro Hashimoto University of Yamanashi |
||
| ● | “Pharmacological basis of traditional medicine as curative polypharmacy
in the 21st century” |
|
| Dr. Takeshi Miyata Kumamoto University |
||
| ● | “GABAB receptor – structure and function in alimentary tract” | |
| Dr. KohtaroTaniyama | ||
| Nagasaki University | ||
| Keynote Lectures | ||
| ● | “Schizophrenia and the mode of functions of the risk factors in neurons” | |
| Dr. Kozo Kaibuchi Nagoya University |
||
| ● | “In search of new chemotherapy for cancer using mouse models” | |
| Dr. Makoto M. Taketo Kyoto University |
||
| Symposia | ||
| ● | Potential drug targets for schizophrenia | |
| ● | RNAi provides a new approach to drug discovery and development | |
| ● | Analysis of transporters responsible for drug action and adverse effects | |
| ● | New development of nitric oxide research | |
| ● | Genome-based screening - new strategies and concepts | |
| ● | New functions of purinergic receptors in CNS: Novel drug targets | |
| ● | Influences of environmental chemical pollutants on brain neuronal functions | |
| ● | Progress in allergy signal research of mast cell | |
| ● | New step of live imaging - from a molecule to whole body | |
| ● | Novel animal models as research tools for functional psychiatric diseases | |
| ● | Pros and cons of in vitro study for evaluation of pharmacological effects | |
| ● | Regulation of immune response by autacoids and neurotransmitters | |
| ● | Biosimulation in drug-development | |
| ● | Gender difference and drugs | |
| ● | New models for functional analysis in life sciences | |
| ● | Involvement of CaM-kinase family in brain disease and medicine | |
| ● | Animal experiments recommended by Japanese Pharmacological Society (Evaluation and decrease of pain) | |
| ● | Chemical biology and drug discovery | |
| ● | Molecular mechanism and novel therapeutic strategies of vascular diseases | |
| ● | G protein-coupled receptors & signal molecules as drug targets | |
| ● | Frontier of research in gastrointestinal diseases | |
| ● | From molecule to brain: integrative approaches toward dynamics of neural circuit assembly and neural functions | |
| ● | Strategies for treatment of life style-related diseases | |
| ● | Intractable progressive neural diseases; Recent studies and therapeutic strategies | |
| ● | Novel roles and drug targets of physiologically active peptides | |
| ● | Various function of circadian clock genes - from diseases to clinical drugs | |
| ● | Pharmacogenomics for pharmacokinetics, pharmacodynamics and toxicodynamics: Comparative pharmacogenomic analysis of the inter-individual variability and species differences | |
| ● | Basic and clinical research of neuroprotection - Approaches from glutamate, endoplasmic reticulum (ER) stress, and amyloid | |
| ● | Device function of salivary glands utilized for systemic diagnosis and therapy | |
| ● | Recent advances of non-invasive molecular imaging | |
| Publication | ||
| ● | Proceedings of the Meeting will be published in the Journal of Pharmacological Sciences as Supplement 1 of Vol. 100, 2006. | |
| HOME |